Oct. 24 at 2:42 PM
$NMRA HC Wainwright reiterates
$18 price target for Neumora stock. This is the second time they have reiterated the
$18 price target, as well as their initial posting of this price target. Maybe this could be a big pharma buy-out price in 2026? NMRA was trading in the
$17 price range earlier this year.
https://www.investing.com/news/analyst-ratings/hc-wainwright-maintains-buy-rating-on-neumora-stock-ahead-of-obesity-drug-data-93CH-4304410